4 December 2023
- 12:3212:32, 4 December 2023 diff hist +60 Facility: Chaplaincy and coordination of worship (Centre Henri Becquerel) No edit summary
- 12:3212:32, 4 December 2023 diff hist +60 Facility: Le Petits Becques (Centre Henri Becquerel) No edit summary
- 12:3212:32, 4 December 2023 diff hist +60 Facility: Hospitality Hotel (Centre Henri Becquerel) No edit summary
- 12:3112:31, 4 December 2023 diff hist +60 Novel Therapies and Diagnostic Methods (Centre Henri Becquerel) No edit summary
- 12:3112:31, 4 December 2023 diff hist +61 Trainings: Henri-Becquerel Education (Centre Henri Becquerel) No edit summary
- 12:3112:31, 4 December 2023 diff hist +61 Trainings: Henri-Becquerel Training Institute (Centre Henri Becquerel) No edit summary
- 12:3012:30, 4 December 2023 diff hist +61 Experts (Centre Henri Becquerel) No edit summary
- 12:2912:29, 4 December 2023 diff hist +18 Centre Henri Becquerel →Trials
- 12:2812:28, 4 December 2023 diff hist +7 Centre Henri Becquerel →Trials (Centre Henri Becquerel)
- 12:2812:28, 4 December 2023 diff hist +453,830 N Trials (Centre Henri Becquerel) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Centre Henri Becquerel page '''NCTID''': NCT04712097 '''Title''': A Study Evaluating the Efficacy and Safety of Mosunetuzumab in Combination With Lenalidomide in Comparison to Rituximab in Combination With Lenalidomide With a US Extension of Mosunetuzumab in Combination With Lenalidomide in Participants With Follicular Lymphoma '''Study Summary''': This study will evaluate the efficacy and safety of..."
- 12:2612:26, 4 December 2023 diff hist −5 Centre Henri Becquerel →Trials
- 12:2612:26, 4 December 2023 diff hist +91 Facility: Les Kyklos (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2512:25, 4 December 2023 diff hist +91 Facility: The Saint-Jean Parents House (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2512:25, 4 December 2023 diff hist +91 Facility: Media Library (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2512:25, 4 December 2023 diff hist +91 Facility: The Health Information House (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2512:25, 4 December 2023 diff hist +91 Novel Therapies and Diagnostic Methods (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2412:24, 4 December 2023 diff hist +92 Internship: Paramedical Trainees (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2312:23, 4 December 2023 diff hist +92 Experts (Cancer Institute AP-HP. Nord - Université de Paris) No edit summary
- 12:2112:21, 4 December 2023 diff hist +7 Gustave Roussy →hasClinicalTrial::Trials (Gustave Roussy)
- 12:1912:19, 4 December 2023 diff hist +866,311 Trials (Gustave Roussy) No edit summary
- 12:1312:13, 4 December 2023 diff hist −193 Gustave Roussy →Trials
- 00:0500:05, 4 December 2023 diff hist +77 Resource: Socio-Beautician (Georges-François Leclerc Cancer Center) No edit summary
- 00:0500:05, 4 December 2023 diff hist +77 Facility: ERI (Meeting and Information Space) (Georges-François Leclerc Cancer Center) No edit summary
- 00:0500:05, 4 December 2023 diff hist +77 Facility: Art and Culture (Georges-François Leclerc Cancer Center) No edit summary
- 00:0400:04, 4 December 2023 diff hist +77 Facility: Library (Georges-François Leclerc Cancer Center) No edit summary
- 00:0400:04, 4 December 2023 diff hist +77 Facility: The Hospitality Home (Georges-François Leclerc Cancer Center) No edit summary
- 00:0400:04, 4 December 2023 diff hist +77 Novel Therapies and Diagnostic Methods (Georges-François Leclerc Cancer Center) No edit summary
- 00:0300:03, 4 December 2023 diff hist +78 Trainings: Paramedical Training (Georges-François Leclerc Cancer Center) No edit summary
- 00:0300:03, 4 December 2023 diff hist +78 Trainings: Continuing Professional Training (Georges-François Leclerc Cancer Center) No edit summary
- 00:0200:02, 4 December 2023 diff hist +97 Courses: University and Post-University Education (Georges-François Leclerc Cancer Center) No edit summary
- 00:0100:01, 4 December 2023 diff hist +78 Experts (Georges-François Leclerc Cancer Center) No edit summary
- 00:0000:00, 4 December 2023 diff hist +25 Georges-François Leclerc Cancer Center →Trials (Georges-François Leclerc Cancer Center)
3 December 2023
- 23:5923:59, 3 December 2023 diff hist +91,722 N Trials (Georges-François Leclerc Cancer Center) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Georges-François Leclerc Cancer Center page '''NCTID''': NCT02947685 '''Title''': Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer '''Study Summary''': The primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus endocrin..."
- 23:5823:58, 3 December 2023 diff hist −5 Georges-François Leclerc Cancer Center →Trials
- 23:5823:58, 3 December 2023 diff hist +54 Facility: The Meeting and Information Space (Institut Godinot) No edit summary
- 23:5723:57, 3 December 2023 diff hist +54 Novel Therapies and Diagnostic Methods (Institut Godinot) No edit summary
- 23:5723:57, 3 December 2023 diff hist +55 Training: Continuing Training (Institut Godinot) No edit summary
- 23:5723:57, 3 December 2023 diff hist +55 Training: Initial Training (Institut Godinot) No edit summary
- 23:5623:56, 3 December 2023 diff hist +55 Experts (Institut Godinot) No edit summary
- 23:5623:56, 3 December 2023 diff hist +7 Institut Godinot →Trials (Institut Godinot)
- 23:5223:52, 3 December 2023 diff hist +243,725 N Trials (Institut Godinot) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Institut Godinot page '''NCTID''': NCT03943667 '''Title''': Gemcitabine and Paclitaxel vs Gemcitabine Alone After FOLFIRINOX Failure in Metastatic Pancreatic Ductal Adenocarcinoma '''Study Summary''': This study aims to evaluate whether the combination of gemcitabine and paclitaxel allows to improve the overall survival compared to gemcitabine alone, in patients with metastatic Pancreatic Ductal Aden..."
- 23:5023:50, 3 December 2023 diff hist −5 Institut Godinot →Trials
- 23:4923:49, 3 December 2023 diff hist +71 Tool: MonICM (Institut du Cancer de Montpellier) No edit summary
- 23:4923:49, 3 December 2023 diff hist +71 Facility: Worship (Institut du Cancer de Montpellier) No edit summary
- 23:4923:49, 3 December 2023 diff hist +71 Facility: Hair Salon (Institut du Cancer de Montpellier) No edit summary
- 23:4923:49, 3 December 2023 diff hist +71 Facility: Transports (Institut du Cancer de Montpellier) No edit summary
- 23:4923:49, 3 December 2023 diff hist +71 Facility: Accommodations (Institut du Cancer de Montpellier) No edit summary
- 23:4923:49, 3 December 2023 diff hist +71 Resource: Interpreter (Institut du Cancer de Montpellier) No edit summary
- 23:4823:48, 3 December 2023 diff hist +71 Resource: Music Therapy (Institut du Cancer de Montpellier) No edit summary
- 23:4823:48, 3 December 2023 diff hist +71 Resource: Art Therapy (Institut du Cancer de Montpellier) No edit summary
